NCT06385925
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06385925
Title A Study of TSN1611 Treating Patients with Advanced Solid Tumors Harboring KRAS G12D Mutation
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Tyligand Pharmaceuticals (Suzhou) Limited
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
NEXT Oncology RECRUITING San Antonio Texas 78229 United States Details
NEXT Virginia RECRUITING Fairfax Virginia 22031 United States Details
Beijing Cancer Hospital, Beijing, China RECRUITING Beijing 100142 China Details
Shanghai Chest Hospital, Shanghai, China RECRUITING Shanghai 200030 China Details
Shanghai Zhongshan Hospital, Shanghai, China RECRUITING Shanghai 200032 China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field